1. Introduction
Non-contrast chest computed tomography (CT) has many advantages over the planar chest X-ray (CXR) such as the better spatial and densitometric resolution and the possibility of a more clear identification of morphologic features of lesions [1]. Although chest CT can provide early diagnosis of COVID-19 pneumonia, it is not sufficient for that purpose considering that it is a specific (COVID-19 pneumonia patterns are similar to the ones of other pneumonia), and the World Health Organization set as the reference standard, in this diagnosis, the transcription-polymerase chain reaction which detects viral nucleic acid [2]. As already discussed in literature, chest CT can be used for the study of COVID-19 progression in patients providing quantitative information [3]. However, this approach needs several scans in a short time window giving rise to additional risks such as an increased possibility of cancer induction, because CT scan can expose a patient to as much radiations as 20–70 chest X-rays (CXR) [4]. In addition, when used for evaluating COVID-19 patients, difficult and time- consuming procedures of decontamination have to be set after each scan, originating either increasing cost for the patient and reducing availability time of the CT. Recent guidelines of the North American Radiology Scientific Expert Panel have assessed that portable CXR has to be considered as the main imaging approach in evaluating COVID-19 patients [5] which not only reduces radiations for patients, but also avoids their transportation. The additional advantage of portable CXR is the possibility to monitor patients in the intensive care units (ICUs) which are more than 5% of the total known cases of COVID-19. Recent clinical studies [6,7] confirm that CXRs can be used in describing some features in COVID-19 patients. The protocol to use CXR for evaluating COVID-19 patients has been set in the Hospital ‘Policlinico G. Martino’ of Messina (Italy) since the beginning of February 2020. In particular, an anteroposterior grey scale CXR in supine position has been acquired for each patient at bed with portable X-ray equipment. Those images are often of low quality for the environment difficulties [8,9,10] as well as for non-collaborative and severely ill patients in most cases [11,12] causing many different artifacts originating inhomogeneities in luminance distribution of radiograms [13]. To overcome these limitations that can impact on diagnostic effectiveness, here we develop a nonlinear post-processing tool, which we named Pipeline for Advanced Contrast Enhancement (PACE) which is aimed at improving the image quality of the CXR as evaluated in terms of contrast improvement index (CII), image entropy (ENT), and the measurement of enhancement (EME).
Other imaging methods such as Optical Coherence Tomography (OCT), Ultrasonography (US) and Magnetic Resonance Imaging (MRI) can be used to study the lungs but with different purposes as compared with CXRs and CTs. OCT has been proposed to potentially replace tissue biopsy for lung cancer diagnosis [14]. US is reliable in diagnosing pleural effusion and pneumothorax but air in the lungs constitutes a barrier for ultrasound. For this reason, US is not as effective as CT in evaluating lung disease [15]. MRI has the advantage of not using ionizing radiation but has a lower spatial resolution than CT. However, MRI faces big difficulties in imaging lungs because air contains few hydrogen atoms. Moreover, molecular oxygen is paramagnetic and causes artifacts at air-soft tissue interfaces (e.g., between lung vessels and alveolar air). In general, MRI is not used for routine lung examination although its specificity in diagnosing mucinous adenocarcinoma has been demonstrated [16,17].
2. Method
Figure 1 shows a block diagram of PACE. As step one, the CXR is processed with the Fast and Adaptive Bidimensional Empirical Mode Decomposition (FABEMD) which decomposes the input image into multiple hierarchical components named bidimensional intrinsic mode functions (BIMFs) and a bidimensional residual image (BR). The residual image is filtered with a Homomorphic Filter (HMF) with a High-Frequency Emphasis Filter (HEF) as kernel function. The CXR is then reconstructed combining the BIMFs with the filtered residual image. The last step of PACE is the use of the Contrast Limited Adaptive Histogram Equalization (CLAHE) to improve the contrast and generate an enhanced CXR (ECXR) image. The performance of the algorithm has been evaluated in 79 patients showing a stable and remarkable improvement on each of the considered metrics (i.e., CII, ENT, EME) against state-of-the-art methods.
To evaluate the clinical impact of the post-processed images, two radiologists have independently analyzed the lung lesions. They have subjectively found in all the enhanced images a clearer definition of the lesions already detectable in the original images and, interestingly, more lesions have been found in 8 cases (>10%). In 3 out of 8 cases, the baseline CXR have been evaluated as negative. The positivity in the enhanced images of those cases has been confirmed by chest CT. This work paves the way for the development of sophisticated post-processing tools to improve the image quality of the cost-effective portable CXR for the monitoring of COVID-19 patients and all patients in the intensive critical unit as well. We argue that this research can be also used as a support of clinical activities either in poor regions where CT is not available and hospitals in developed countries at the peak of the COVID-19 pandemic. In addition, PACE can be used as a tool for preprocessing CXR data or data augmentation in machine/deep learning approaches, such as segmentation and classification, with a possible application in early diagnosis of COVID-19 [18,19,20].
3. Description and Performance Evaluation of the Algorithm
3.1. Fast and Adaptive Bidimensional Empirical Mode Decomposition—FABEMD
The algorithm of FABEMD [21] estimates the intrinsic mode functions (IMFs) in a bi-dimensional space (BIMFs). It uses a variable window order-statistics filter and an iterative procedure to identify a finite number of BIMFs and a BR representing the latent information. The BIMFS are numbered from the faster to the slower ones. Compared to other approaches used to extract the BIMFs, FABEMD is fast because it does not need a recursive approach for the calculation of each IMF [22]. The implementation of FABEMD algorithm can be summarized by the following steps.
Step 1—Local maxima and minima detection
The j-th BIMF of an image is obtained by a neighboring window method [22]. The minima and maxima of are collected in a 2D matrix ( are the row and column respectively) and are obtained by window size as follows:
(1)
where [21]:(2)
Step 2—Size of order-statistic filter window calculation
and are defined to be the adjacent maximum and minimum array distance, respectively. Their values are calculated from each local maximum or minimum point to the nearest nonzero element and then sorted in a descending order. The gross window width is computed as follows:
(3)
Step 3—Application of the order statistics and smoothing filters
The upper and lower envelopes are computed from two functions and defined as:
(4)
where is a square region having the window size, and is the window width of the smoothing filter. Equation (4) describes the operation of arithmetic mean filters which is used to smooth local variances. The average envelope is calculated by using the smoothed envelopes and . Therefore, the MAX and MIN filters are collected in a new 2-D matrix for the envelope surface [23].FABEMD has been used for different purposes in medical imaging [24] including image retrieval [25] and fusion [26,27]. Here, we have used FABEMD to separate the low varying (latent) from high varying components of CXRs with the aim to correct the luminance contributions while preserving the other information. Figure 2 shows an example of the BIMFs as calculated with FABEMD. In order to evaluate the relevance, in terms of information contents, of a BIMF, we have computed its energy E following the approach provided in Ref. [28]. By comparing the BIMFs with the original image, the more informative BIMFs are the panels (d)–(f). In particular, we noted that the edges are well represented on panel (d), the signal is contained in panel (e) while the contrast is mainly in panel (f). On the other hand, the residual image in panel (j), representing the latent information, clearly shows the non-uniform luminance of the original image. Similar results have been also observed for the other images.
We wish to highlight that the meaning of the BIMFs of Figure 2 does not depend on the type of information content of CXR (normal, pneumonia, etc.) and FABEMD extracts, and isolates specific features of the input image such as edges, noise, low and high frequency components, and background. Once this information is coded in the BIMFs, it is possible to filter or perform a selective image reconstruction with the aim to improve the global information of the original image.
3.2. Homomorphic Filtering—HMF
The log-transformed residual image is then filtered with an HMF— for correcting the non-uniform illumination of the CXR [29,30]. We stress one more time that the HMF is used to reduce inhomogeneous effects of CXRs. It is built with a High-Frequency Emphasis Filter (HEF) [13] given by:
(5)
where and , respectively.From a theoretical point of view, an image ((x, y) are the spatial coordinates) can be expressed as a product between reflectance of the object or scene and the intensity of the illumination , which represents the image noise, [31]. The undesired effect of can be filtered in the log domain considering the log-transformed image [32,33]:
(6)
and its Fourier Transform (FT) is given by:(7)
where and are the FT of and respectively. The filtered image is computed as , being the inverse FT of the convolution between and as(8)
The setting parameters are and which have been computed by using multi-objective optimization (MOO) [34,35,36]. Figure 3 shows an example of the application of the HMF applied to the BR achieved with the FABEMD algorithm displayed in Figure 2j. In summary, HMF represents the intermediate step in our pipeline and it has been implemented to integrate such filtering process with FABEMD and to prepare the image, via a reconstruction block, for a contrast enhancement achieved by means of CLAHE. The reconstruction block combines the BIMFs with the filtered BR that will be then processed to generate a final single CXR with improved contrast, preserved details and where the illumination inhomogeneities are dramatically reduced.
3.3. Contrast Limited Adaptive Histogram Equalization—CLAHE
CLAHE is a generalization of the Adaptive Histogram Equalization [37]. For a given input image, the algorithm of CLAHE creates non-overlapping contextual regions (also called sub-images, tiles or blocks) and then applies the histogram equalization to each contextual region, clips the original histogram to a specific value and then redistributes the clipped pixels to each gray level. The size of the contextual region or block size (BS) is typically computed at the point where the maximum entropy curvature is achieved [38]. The Clip Limit (CL) for the calculations is 0.01 as suggested in Ref. [39], whereas the BS is empirically determined in 16 × 16 pixels. The redistributed histogram is different from an ordinary histogram because each pixel intensity is limited to a selected maximum. However, either the enhanced image and the original image exhibit the same minimum and maximum gray values. In detail, for enhancing the intensity values in each contextual region, we have used a uniform distribution, because it has demonstrated to provide better results as suggested in Ref. [40]. Finally, the calculation of the new gray-level assignment of the pixels is achieved within a sub-matrix contextual region by using a bi-linear interpolation between four different mappings to eliminate boundary artifacts. CLAHE was already applied for the enhancement of contrast in medical images [30,41,42,43]. Huang proposed CLAHE-DWT (DWT is for discrete wavelet transform) using a combination of CLAHE and DWT to overcome the limitations of CLAHE which faces the contrast overstretching and noise enhancement problems. This aspect is central because bright parts of the image are unnecessary to be enhanced with respect to the dark ones. The proposed approach motivates the proper combination of CLAHE, FABEMD and HMF to exploit both direct component segmentation capabilities of the former and correction benefits of the latter to stabilize and preprocess the image before CLAHE is applied.
3.4. Metrics Definition
Nowadays, specific processing methods are available [44] to enhance image quality for specific applications [45,46]. In order to assess the improvement, different enhancement metrics can be considered [47]. Previous works have demonstrated that the combination of several enhancement techniques is required to improve the overall image quality. In PACE, the improvement is focused on homogeneous contrast, visibility, and image detail as they are the most essential and important factors that are used in detection, recognition, and monitoring of lung lesions especially for COVID-19 patients. With this in mind, we have evaluated performance of PACE, considering as reference metrics the CII, the ENT and EME.
3.4.1. Contrast Improvement Index (CII)
According to the literature, the CII is defined as follows [48]:
(9)
where and are the contrast values of the processed and original image, respectively. The contrast C of a region is defined as [47]:(10)
p(k) being the probability to have a specific gray-level value.3.4.2. Entropy—ENT
The entropy, [49] which is a measure of the randomness characterizing the texture of the image, is estimated by the histogram of the image considered as a whole:
(11)
where p is the histogram count for an image segment. In general, there are more complex metrics based on entropy such as measure of enhancement by entropy (EMEE) [50]. However, as pointed out in literature by Gupta et al. [51] and Panetta et al. [52], EMEE is suitable for images with attributes like noncomplex segments or small-size complex segments, non-periodic patterns in segments, and randomness because of the inclusion of entropy. EMEE has been suggested for assessing nodule enhancement [53,54] rather than for the evaluation of contrast enhancement in larger areas, which makes EMEE not appropriate for this specific study.3.4.3. Measure of Enhancement—EME
For an image split into blocks of size , EME is defined as [45]:
(12)
where represents the block considered for the calculations, EMErc depends on the image segmentation into blocks and the contrast (as calculated in the block ) is defined as [55]:(13)
being and are the maximum and minimum intensity levels, respectively, for the image inside . The value c is a small constant which is equal to 0.0001 to avoid dividing by 0. The EME measure is suitable for images with attributes like noncomplex segments (e.g., regular geometrical shapes, like for human body parts), non-periodic pattern in segments, and little to no randomness in segments [55]. In addition, many literatures on contrast enhancement [56,57,58,59] adopted EME as an evaluation indicator including contrast enhancement in mammographic images, [60] or in brain and breast cancer images [55].4. Results and Discussion
4.1. Evaluation of the Algorithm Performance
To demonstrate the performance of the proposed method, 79 baseline CXR images of COVID-19 patients from the University Hospital ‘Policlinico G. Martino’ in Messina have been analyzed. The original CXR images (3520 × 4280 pixels; 10-bit grayscale; grayscale value is 0–1024, spatial resolution, 0.175 mm/pixel) are subsampled by 4 to reduce the processing time to 1 min per single image. Figure 4a–c provide a quantitative comparison of the metrics discussed in the previous paragraph, (a) CII, (b) ENT, and (c) EME, as computed in images enhanced with CLAHE (red empty triangles) and PACE (blue empty circles) for all the 79 patients. The values are plotted in descending order considering the results of PACE; the same order of images enhanced with CLAHE is used and therefore, those curves (red triangles) are nonmonotonic. An improvement for all the images based on all the three metrics have been obtained. An average increase of 10% in CII, 7.5% in entropy, and 4.7% in EME have been documented.
Figure 4a–c provide a comparison between CLAHE (red triangles) and PACE (solid blue line) considering (a) the contrast index improvement metric, (b) the image entropy, and (c) the measure of enhancement. The metrics are computed on a dataset of 79 baseline CXR images from COVID-19 patients, and the values have been ordered via descending order considering the results achieved with PACE. The three metrics show the better performance of PACE over CLAHE.
A visual example of a CXR enhancement, acquired with the portable X-ray equipment, is shown in Figure 4d–f, where the original CXR (panel (d)), post-processed with CLAHE (panel (e)) and with the approach proposed here (panel (f)) are displayed, respectively. To better show the improvement, Figure 4g–i provide a magnified region for evaluating a specific part of the images.
The performance of PACE has been also benchmarked in a public database (
Recent research contributions for X-ray image enhancement [62,63,64,65] worthwhile to be mentioned, and their similarities and differences are highlighted in the following pages. In Reference [62], the method uses image fusion and filtering/sharpening techniques to resolve problems such as noise and blurriness in degraded X-ray images. We do not use image fusion because this study was originally conceived for COVID-19 patients whose conditions (especially in the ICUs) are such that it is very difficult to have consecutive CXRs to be used for fusion. On the other hand, we do consider a filtering stage in our processing pipeline to correct for brightness inhomogeneities by using Homomorphic Filtering. In Ref. [63], Fruit fly optimization algorithm is used to optimize a fuzzy enhancement algorithm for medical image enhancement. Differently from this approach, we have used Multi-Objective Optimization (MOO) to achieve optimization of the filtering parameters that are used into the HMF stage of the processing pipeline. Furthermore, we compared our results using standard metrics (CII, ENT and EME) and we used a larger dataset of CXR patients.
In Reference [66], the method uses a processing pipeline composed of a two-stage filtering process (adapting median filter and bilateral filter, respectively) and CLAHE. Similarly, we consider either HMF for the filtering part and CLAHE for the contrast enhancement part. Differently, we have introduced the FABEMD to perform an adaptive isolation of image feature and to achieve a more selective filtering of the image components. In addition, we perform evaluation of the results using well-known metrics (CII and ENT) other than Peak signal-to-noise ratio (PSNR) and Structural Similarity Index (SSIM). Although the structural similarity index family is a set of metrics that has demonstrated good agreement with human observers in tasks using reference images, some studies show limits in the performance of these indices when analyzing medical images [67,68].
In Reference [65], the method used for performing Medical X-ray Image enhancement adopts a new kind of Homomorphic Filtering, which is called Total Variation (TV) Homomorphic Filter. In order to evaluate its performance, different metrics are used, including mean value, ENT, average gradient and average Laplacian. This Homomorphic Filter can be also used for PACE.
In addition, we have evaluated the image contrast enhancement with other methods listed below, selected by checking other works [69,70,71,72,73]:
Adaptive Gamma Correction with Weighting Distribution (AGCWD) [74]
Contrast Enhanced Gamma Correction (CEGAMMA) [75]
Exposure-based Sub-Image Histogram Equalization (ESIHE) [76]
Median-Mean-based Sub-Image Clipped Histogram Equalization (MMSICHE) [73]
Recursive Sub-Image Exposure-based Histogram Equalization (R-ESIHE) [76]
Dominant Orientation-based Texture Histogram Equalization (DOTHE) [72]
Contrast Limited Adaptive Histogram Equalization (CLAHE) [38].
Table 1 summarizes the results for: AGCWD, CEGAMMA, ESIHE, MMSICHE, R-ESIHE, DOTHE, CLAHE, and our method (PACE) using a dataset composed of 163 CXR images from patients affected by different pulmonary diseases (including lung cancer, pneumonia, mucoviscidosis, pulmonary fibrosis, pulmonary sarcoidosis, pleural effusion and COVID-19) furnished by the Hospital ‘Policlinico G. Martino’ of Messina (Italy).
An improvement for all the images based on the three metrics have been obtained. An average increase of 11% in CII and 5% in entropy have been documented.
4.2. Radiological Evaluation and Statistics
For each of the 79 patients with laboratory-confirmed COVID-19 who underwent a bedside chest X-ray, two radiologists were asked to express their opinion about: (i) presence of pneumonia (negative or positive) and (ii) assessment of diagnostic improvement with CXR images enhanced with PACE. The evaluation procedure followed a standard procedure, it was carried out separately by the two radiologists in one session and a final agreement was then calculated.
The agreement about both the presence of pneumonia and the diagnostic improvement was calculated with the inter-observer agreement K-value and the statistical significance p. In this evaluation, the values computed are K = 0.933 and p < 0.001. The sensitivity defined as the number of positive diagnosis over the true COVID-19 positive (confirmed by the transcription-polymerase chain reaction) was 69%. Post-processed images improved the detection of lesions in 8 out 79 patients (≅10%), and in 3 patients allowed detection of lesions not visible on not-processed CXRs.
In general, from a radiological point of view, the key achievement is that the number of lesions identified in the original image and the one post-processed with CLAHE is the same, while PACE shows the capability to enhance the quality of the CXR enough in order to find more lesions when present. This result is confirmed in 8 patients; for the other cases, while the number of lesions is the same for the three images (original, CLAHE, and our method), the velocity of lesion search has been improved as confirmed independently by a third radiologist. To support our claims in those cases, we have also performed the CT scans. Figure 5 shows a comparison among the original CXR image (panel a), the corresponding CT scan (panel b), and the enhanced CXR (panel c) as computed with PACE. Baseline CXR (a) shows a large peripheral ground-glass pneumonia in the left lung indicated with arrowheads. No lesions can be seen in the right lung. On the other hand, on the enhanced image (c), left lung pneumonia (arrowheads) is better visible as well as further focus of pneumonia in the right lung (arrow). Maximum intensity projection of isotropic coronal reconstruction (b) confirms the presence of both the large left lung lesion (arrowheads) and the small focus of pneumonia in the right lung (arrow). We highlight that on the baseline radiogram it is present as (a) overexposition of the right lung due to slight rotation of the patient. On the enhanced image (c), overexposition has been corrected. To analyze how details are preserved and contrast enhanced, in Figure 5d–f show a magnified region for original (d), CT scan (e) and enhanced image (f), respectively. Indeed, a more important aspect is accomplished in 3 cases of the 8 cited above. In those specific cases, it has not been possible to detect any lesions in the original and the CLAHE images, while lesions have been found in the image enhanced by our approach. Such results have been confirmed by the CT scans.
An example for those cases is shown in Figure 6, where a comparison among original CXR image (a), the corresponding CT scan (b) and the enhanced CXR (c) is displayed. Baseline CXR does not show any lesions. However, both the CT scan and the enhanced image (see arrow) show the presence of a lesion in the left lung. A zoom of the area where this specific lung lesion is located is investigated in panels (d–f). Here, the magnified region is shown from the original image (d), CT scan (e) and with PACE (f), respectively. PACE enables to identify the lesion (black arrow) which is not visible using original CXR. The lesion in confirmed by evaluating the CT scan (white arrow) (e).
While developed for supporting the monitoring of COVID-19 patients, PACE can be also used to improve the image contrast for other possible scenarios as shown in the two examples of Appendix A. For those cases, the CT also confirms the additional information which can be caught from the enhanced CXR.
5. Conclusions
Medical imaging has a significant impact on medical applications, and since the quality of healthcare directly affects the quality of living of a patient, using the images for improving the performance of the medical specialists is an important issue [79]. We have developed an automatic post-processing tool to enhance CXR images for the detection of lung lesions. These results are generally applicable to image enhancement. On the other hand, the capability to support image monitoring of the healthy status of COVID-19 patients has been tested in 79 patients. From a clinical point of view, the image enhancement induced by the method implemented in this work originated (i) a faster detection of lung lesions in general, (ii) in 8 cases, it was able to highlight additional lesions, while (iii) in 3 out of the 8 cases, lesions have been detected in the enhanced CXR image while baseline CXR did not show any lesions. The clinical findings have been evaluated by two radiologists, initially independently of each other, and a third consultancy has been further used for confirmation. In addition, CT scan verification substantiates the achievement observed in enhanced CXR.
From a technical point of view, the improved performance of PACE approach has been confirmed by three well-known metrics, (i) contrast improvement index, (ii) entropy, and (iii) measure of enhancement. The analysis of these metrics shows that this method preserves the input image details more accurately and gives a processed image with better contrast enhancement and reduced brightness inhomogeneities. Concretely, we believe that this tool can support the clinical assistance of COVID-19 patients by enhancing the readability of CXR attained by portable X-ray equipment and, in addition, furnishing capability to monitor patients in intensive care units.
Author Contributions
G.S. implemented the algorithm and the methodology supported by A.L.C.; G.S., M.G., M.C. and G.F. developed the idea; G.F. coordinated the work; M.G. and G.C. cured the clinical part. G.F. wrote the paper with input from G.S. and M.G. The validation part has been accomplished by G.S., M.G. and G.F. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Acknowledgments
This work was partially supported by PETASPIN association and MARIS s.c.a.r.l.
Conflicts of Interest
The authors declare no conflict of interest.
Ethical Statement
The Ethical Committee at the University Hospital of Messina does not require approval for a work on retrieved and anonymized data. For any information, contact the secretary of Ethical Committee at the University Hospital of Messina at the contact information posted on its website (
Data Availability
The data that support the plots within this paper and other findings of this study are available from the corresponding authors upon reasonable request.
Appendix A
Figure A1a shows a CXR, obtained in supine position, of a patient hospitalized in an intensive care unit after blunt thoracic trauma where pulmonary contusions were suspected with low diagnostic confidence both in the left and in the right lung (asterisks). On the enhanced CXR (Figure A1b), a large retrocardiac area of attenuation due to the contusion of the left lower lobe can be seen. Air-containing bronchi are also visible within the contusion (black arrow). In addition, a smaller and inhomogeneous contusion (white arrows) can be detected with high confidence in the right lower lobe close to the right edge of the heart (R). Figure A1c shows the chest CT coronal reconstruction, which confirms the lung contusions in the left (L) and right (white arrows) lower lobes as well as bronchi (black arrow) within the left contusion. CT correlates perfectly with the enhanced CXR.
Figure A1
A comparison among (a) original CXR image, (b) enhanced CXR image using PACE and (c) CT image for a non-COVID-19 case.
[Figure omitted. See PDF]
Figure A2a shows the CXR of a patient with hemoptysis where a nodule was suspected in the right upper lobe (arrow). The enhanced CXR allows to detect the nodule with higher confidence (Figure A2b) and with more details about the shape. The coronal CT reconstruction in Figure A2c confirmed the speculated nodule in the left lung. A transthoracic biopsy yielded pulmonary adenocarcinoma.
Figure A2
A comparison among (a) original CXR image, (b) enhanced CXR image using PACE and (c) CT image for a non-COVID-19 case (a patient with hemoptysis).
[Figure omitted. See PDF]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures and Table
Figure 1. A block diagram of the PACE method developed in this work. The input Chest X-ray (CXR) is converted into an Enhanced CXR (ECXR) through different steps. (I) Fast and Adaptive Bidimensional Empirical Mode Decomposition (FABEMD) generates the bi-dimensional intrinsic mode functions (BIMFs) and a bidimensional residual image (BR), (II) the Homomorphic Filtering (HMF) block filters the BR to correct brightness inhomogeneities. Finally, (III) Contrast Limited Adaptive Histogram Equalization (CLAHE) is applied on the reconstructed image (BIMFs + filtered BR) to improve the overall contrast and generate the ECXR.
Figure 2. (a)–(j): An example of BIMFS computed with the FABEMD decomposition. (a) Original image; (b) BIMF #1 and (c) BIMF #2, which contain highly varying components with very low amplitude; (d) BIMF #3; (e) BIMF #4 and (f) BIMF #5 display more components with more information content. The panels (g) BIMF #6; (h) BIMF #7, (i) BIMF #8 and (j) BIMF #9 represent the low varying components while (k) shows the bidimensional residue (BR) of the calculation.
Figure 3. (a) Residual image as obtained from FABEMD of the same input CXR image as processed in Figure 2 (panel j); (b) Residual image after being processed using the HMF. As shown, the non-uniform luminance of the image has been significantly corrected (see red arrows as reference).
Figure 4. (a–f). The panels (a–c) show a comparison of performance between a literature reference algorithm (CLAHE) (empty red triangles) and the one proposed in this work (empty blue circles) evaluated with three metrics (a) contrast improvement index (CII), (b) entropy (ENT), and (c) and enhancement measurement (EME). The panels (d–f) show an example of the CXR compared with (d) original image, (e) post-processed with CLAHE, and (f) PACE. Finally, the panels (g–i) provide a magnified area with evidence of how lungs are differently shown in original (g), post-processed with CLAHE (h) and with our method (i). PACE enhances both contrast and details in a better way than state-of-the-art reference methods.
Figure 5. A comparison among (a) original CXR image, (b) CT image and (c) enhanced CXR image using PACE where it is possible to show that the number of lesions found in the enhanced image are more than the one identified in the original image. Finally, the panels (d–f) provide a magnified area with evidence of how lungs are differently shown in original (d), CT image (e) and with our method (f).
Figure 6. A comparison among (a) original CXR image, (b) CT image and (c) enhanced CXR image using PACE. Here, it is possible to see a case where the lesion can be observed in the enhanced image and not in the original one. Lastly, the panels (d–f) provide a magnified area with evidence of how lungs are differently shown in original (d), CT image (e) and with our method (f).
Performance comparison based on entropy (ENT) and CII as expressed in average +/− standard deviation. Results of 163 CXR images from patients with different pulmonary diseases as evaluated using several state-of-the-art methods. The asterisk ‘*’ represents the best method for the metric.
ENT | CII | |
---|---|---|
AGCWD [77] | 6.94 +/− 0.62 | 1.27 +/− 0.33 |
CEGAMMA [75] | 6.84 +/− 0.64 | 0.94 +/− 0.07 |
ESIHE [78] | 6.86 +/− 0.63 | 1.11 +/− 0.18 |
MMSICHE [73] | 6.85 +/− 0.63 | 1.05 +/− 0.1 |
R-ESIHE [76] | 6.77 +/− 0.62 | 1.09 +/− 0.21 |
RS-ESIHE [76] | 6.72 +/− 0.65 | 0.9 +/− 0.23 |
DOTHE [72] | 6.46 +/− 0.59 | 1.23 +/− 0.29 |
CLAHE [38] | 7.27 +/− 0.57 | 1.18 +/− 0.17 |
PACE | * 7.69 +/− 0.2 | * 1.31 +/− 0.24 |
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2020 by the authors.
Abstract
COVID-19 is a new pulmonary disease which is driving stress to the hospitals due to the large number of cases worldwide. Imaging of lungs can play a key role in the monitoring of health status. Non-contrast chest computed tomography (CT) has been used for this purpose, mainly in China, with significant success. However, this approach cannot be massively used, mainly for both high risk and cost, also in some countries, this tool is not extensively available. Alternatively, chest X-ray, although less sensitive than CT-scan, can provide important information about the evolution of pulmonary involvement during the disease; this aspect is very important to verify the response of a patient to treatments. Here, we show how to improve the sensitivity of chest X-ray via a nonlinear post-processing tool, named PACE (Pipeline for Advanced Contrast Enhancement), combining properly Fast and Adaptive Bidimensional Empirical Mode Decomposition (FABEMD) and Contrast Limited Adaptive Histogram Equalization (CLAHE). The results show an enhancement of the image contrast as confirmed by three widely used metrics: (i) contrast improvement index, (ii) entropy, and (iii) measure of enhancement. This improvement gives rise to a detectability of more lung lesions as identified by two radiologists, who evaluated the images separately, and confirmed by CT-scans. The results show this method is a flexible and an effective approach for medical image enhancement and can be used as a post-processing tool for medical image understanding and analysis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Department of Electric, Electronic and Computer Engineering, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy;
2 Department of Biomedical Sciences, Dental and of Morphological and Functional Images, University of Messina, Via Consolare Valeria 1, 98125 Messina, Italy;
3 Istituto Nazionale di Geofisica e Vulcanologia (INGV), Via di Vigna Murata 605, I-00143 Roma, Italy; Maris Scarl, via Vigna Murata 606, 00143 Roma, Italy
4 Istituto Nazionale di Geofisica e Vulcanologia (INGV), Via di Vigna Murata 605, I-00143 Roma, Italy; Department of Mathematical and Computer Sciences, Physical Sciences and Earth Sciences, V.le F. Stagno D’Alcontres 31, University of Messina, 98166 Messina, Italy